Thus, mRNA/LNP vaccination promoted the recruitment of antigen presenting cells as well as CD4+ T cells, and acted in synergy with PD-1 blockade to promote an effective anti-tumor immune response. This evidence concerns the gene PDCD1 and neoplasm.